UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Position in Option Care Health, Inc. (NASDAQ:OPCH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 12.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,045,573 shares of the company’s stock after selling 596,491 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 2.38% of Option Care Health worth $126,626,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Blue Trust Inc. grew its holdings in shares of Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after buying an additional 377 shares in the last quarter. GAMMA Investing LLC grew its stake in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after acquiring an additional 471 shares during the period. Lindenwold Advisors INC raised its holdings in Option Care Health by 5.4% in the 3rd quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock valued at $299,000 after acquiring an additional 489 shares during the last quarter. Trust Point Inc. lifted its stake in shares of Option Care Health by 2.6% during the 3rd quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock worth $755,000 after purchasing an additional 622 shares during the period. Finally, Nisa Investment Advisors LLC boosted its holdings in shares of Option Care Health by 5.4% during the second quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock worth $376,000 after purchasing an additional 690 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $23.80 on Monday. The firm’s fifty day simple moving average is $26.84 and its 200 day simple moving average is $28.87. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.63. The firm has a market capitalization of $4.05 billion, a price-to-earnings ratio of 20.00, a PEG ratio of 2.46 and a beta of 1.32.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on OPCH. Truist Financial reduced their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. JMP Securities raised their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and dropped their price target for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Barrington Research decreased their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. Finally, Bank of America lowered Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $30.83.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.